S Cush
Overview
Explore the profile of S Cush including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
175
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cataliotti L, de Wolf C, Holland R, Marotti L, Perry N, Redmond K, et al.
Eur J Cancer
. 2007 Feb;
43(4):660-75.
PMID: 17276672
According to EUSOMA position paper 'The requirements of a specialist breast unit', each breast unit should have a core team made up of health professionals who have undergone specialist training...
2.
Blanks R, Bennett R, Patnick J, Cush S, Davison C, Moss S
Clin Radiol
. 2005 Jul;
60(6):674-80.
PMID: 16038694
Aim: To assess the effect on cancer detection and recall rates of changing from one to two views for incident (subsequent) screens. Methods: Controlled, comparative, observational study of programmes in...
3.
Quattrocchi K, Miller C, Cush S, Bernard S, Dull S, Smith M, et al.
J Neurooncol
. 2000 Apr;
45(2):141-57.
PMID: 10778730
A prospective pilot study was performed in order to assess the safety of treating recurrent malignant gliomas (MGs) with locally infused autologous tumor infiltrating lymphocytes (TILs) and recombinant interleukin-2 (rIL-2)....
4.
Smith M, Thompson J, Castillo M, Cush S, Mukherji S, Miller C, et al.
AJNR Am J Neuroradiol
. 1996 Jun;
17(6):1065-71.
PMID: 8791917
Purpose: To describe the MR findings in six patients with recurrent cerebral astrocytomas before, immediately after, and 3 months after local immunotherapy with tumor-infiltrating lymphocytes and interleukin-2. Methods: Contrast-enhanced MR...
5.
Day N, McCann J, Britton P, Hurst G, Cush S, Duffy S
J Med Screen
. 1995 Jan;
2(4):180-5.
PMID: 8719145
Interval cancer rates are a major determinant of the success of a screening programme. In the Swedish two county study, on which the United Kingdom programme is based, a 39%...
6.
MAHALEY Jr M, Hipp S, Dropcho E, BERTSCH L, Cush S, Tirey T, et al.
J Neurosurg
. 1989 Mar;
70(3):371-8.
PMID: 2536804
Forty patients with recurrent gliomas were treated with monthly intra-arterial infusions of cisplatin. Of the 35 evaluable patients, 12 (34%) responded with computerized tomography (CT) evidence of a decrease in...
7.
MAHALEY Jr M, BERTSCH L, Cush S, Gillespie G
J Neurosurg
. 1988 Dec;
69(6):826-9.
PMID: 3142970
Recombinant gamma-interferon (2 mg/sq m) was administered intravenously twice weekly in 8-week courses to 14 patients with recurrent gliomas. Computerized tomography (CT) evidence of response was seen in only one...
8.
MAHALEY Jr M, WHALEY R, Krigman M, Bouldin T, BERTSCH L, Cush S
Surg Neurol
. 1987 May;
27(5):430-2.
PMID: 3551160
In 81 patients with anaplastic supratentorial gliomas, single versus multiple chemotherapeutic agents were selected for treatment following surgery and during radiotherapy in a prospective randomized study. Time to treatment failure...